Market Cap 2.92B
Revenue (ttm) 1.14B
Net Income (ttm) 214.61M
EPS (ttm) N/A
PE Ratio 13.17
Forward PE 13.20
Profit Margin 18.86%
Debt to Equity Ratio 0.54
Volume 518,300
Avg Vol 425,622
Day's Range N/A - N/A
Shares Out 48.08M
Stochastic %K 69%
Beta 0.39
Analysts Strong Sell
Price Target $76.67

Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 914 524 6800
Address:
660 White Plains Road, Tarrytown, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:41 AM
Actionable Trade Alert for $PBH: Market Context: $PBH closed at $60.51, showing a bullish sentiment with an RSI of 59.1, indicating potential upward momentum. The price is currently above the 30-day moving average (MA30) of $60.07 but below the 50-day moving average (MA50) of $61.02, suggesting a possible breakout if it can surpass the MA50. Directional Bias: The RSI is nearing overbought territory but still has room to run, indicating a bullish bias. The recent high of $65.16 provides a target for potential gains, while the low of $57.25 offers a solid support level. Trade Plan: - Suggested Entry: $60.51 - Stop Loss: $58.50 (approximately 3.3% below entry) - Take Profit Targets: 1. $62.00 (2.5% gain) 2. $63.50 (4.9% gain) 3. $70.75 (16.9% gain) With a well-defined risk-reward ratio and potential for over 17% ROI on the third target, this trade presents a favorable opportunity. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:40 AM
Actionable Trade Alert for $PBH: Market Context: Currently, $PBH is trading at $60.06, with an RSI of 50.42 indicating neutral momentum. The stock is positioned between its 60-day high of $65.61 and low of $57.25, suggesting potential for movement within this range. Directional Bias: The stock is trading slightly below the 30-day MA of $60.18 and the 50-day MA of $61.11, indicating a bearish short-term trend. However, the neutral RSI suggests that a reversal could be imminent, especially if it breaks above the 30-day MA. Trade Plan: - Suggested Entry: $60.50 (above the 30-day MA) - Stop Loss: $58.50 (below the 60D low) - Take Profit Targets: 1. $62.00 (approx. 2.5% gain) 2. $63.50 (approx. 5.8% gain) 3. $70.00 (approx. 16.5% gain) Target 3 offers a potential ROI of over 17%. Monitor price action closely for signs of strength or weakness. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:15 PM
Actionable Trade Alert for $PBH: Market Context: Currently, $PBH is trading at $60.06, with an RSI of 50.42 indicating neutral momentum. The stock is positioned between its 60-day high of $65.61 and low of $57.25, suggesting potential for movement within this range. Directional Bias: The stock is trading slightly below the 30-day MA of $60.18 and the 50-day MA of $61.11, indicating a bearish short-term trend. However, the neutral RSI suggests that a reversal could be imminent, especially if it breaks above the 30-day MA. Trade Plan: - Suggested Entry: $60.50 (above the 30-day MA) - Stop Loss: $58.50 (below the 60D low) - Take Profit Targets: 1. $62.00 (approx. 2.5% gain) 2. $63.50 (approx. 5.8% gain) 3. $70.00 (approx. 16.5% gain) Target 3 offers a potential ROI of over 17%. Monitor price action closely for signs of strength or weakness. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TimRegan_WTR
TimRegan_WTR Nov. 18 at 6:32 PM
0 · Reply
research_WTR
research_WTR Nov. 18 at 6:22 PM
Prestige Consumer Healthcare (PBH) Posts Solid 2QFY26 — EPS Beat, Strong FCF, and Accelerated Buybacks 🔹 Sales of $274M, down 3.4% Y/Y but ahead of PBH guidance & consensus, helped by earlier-than-expected Clear Eyes inventory and strong online orders 🔹 Clear Eyes supply constraints easing — two new suppliers online; high-speed line coming via Pillar5 acquisition 🔹 Adjusted EBITDA of $86.8M, above expectations, with solid margins 🔹PBH continues to deliver resilient performance, strong cash generation, and disciplined capital allocation — positioning the company well heading into FY26/FY27. Read Douglas M. Lane, CFA full report for more! $PBH #Earnings #ConsumerHealth #ClearEyes #SmallCap #Stocks #Investing #FreeCashFlow #Buybacks
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:57 PM
Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 100 → 88.
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 7 at 2:14 PM
$PBH Current Stock Price: $61.40 Contracts to trade: $60 PBH Nov 21 2025 Call Entry: $3.54 Exit: $6.53 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Nov. 6 at 11:00 AM
$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act
0 · Reply
Estimize
Estimize Nov. 4 at 11:03 PM
Wall St is expecting 0.97 EPS for $PBH Q2 [Reporting 11/06 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 1:36 PM
Oppenheimer has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Outperform with a target price of 82 → 72.
0 · Reply
Latest News on PBH
Prestige (PBH) Q1 Revenue Falls 6.6%

Aug 7, 2025, 6:47 AM EDT - 4 months ago

Prestige (PBH) Q1 Revenue Falls 6.6%


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:41 AM
Actionable Trade Alert for $PBH: Market Context: $PBH closed at $60.51, showing a bullish sentiment with an RSI of 59.1, indicating potential upward momentum. The price is currently above the 30-day moving average (MA30) of $60.07 but below the 50-day moving average (MA50) of $61.02, suggesting a possible breakout if it can surpass the MA50. Directional Bias: The RSI is nearing overbought territory but still has room to run, indicating a bullish bias. The recent high of $65.16 provides a target for potential gains, while the low of $57.25 offers a solid support level. Trade Plan: - Suggested Entry: $60.51 - Stop Loss: $58.50 (approximately 3.3% below entry) - Take Profit Targets: 1. $62.00 (2.5% gain) 2. $63.50 (4.9% gain) 3. $70.75 (16.9% gain) With a well-defined risk-reward ratio and potential for over 17% ROI on the third target, this trade presents a favorable opportunity. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:40 AM
Actionable Trade Alert for $PBH: Market Context: Currently, $PBH is trading at $60.06, with an RSI of 50.42 indicating neutral momentum. The stock is positioned between its 60-day high of $65.61 and low of $57.25, suggesting potential for movement within this range. Directional Bias: The stock is trading slightly below the 30-day MA of $60.18 and the 50-day MA of $61.11, indicating a bearish short-term trend. However, the neutral RSI suggests that a reversal could be imminent, especially if it breaks above the 30-day MA. Trade Plan: - Suggested Entry: $60.50 (above the 30-day MA) - Stop Loss: $58.50 (below the 60D low) - Take Profit Targets: 1. $62.00 (approx. 2.5% gain) 2. $63.50 (approx. 5.8% gain) 3. $70.00 (approx. 16.5% gain) Target 3 offers a potential ROI of over 17%. Monitor price action closely for signs of strength or weakness. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:15 PM
Actionable Trade Alert for $PBH: Market Context: Currently, $PBH is trading at $60.06, with an RSI of 50.42 indicating neutral momentum. The stock is positioned between its 60-day high of $65.61 and low of $57.25, suggesting potential for movement within this range. Directional Bias: The stock is trading slightly below the 30-day MA of $60.18 and the 50-day MA of $61.11, indicating a bearish short-term trend. However, the neutral RSI suggests that a reversal could be imminent, especially if it breaks above the 30-day MA. Trade Plan: - Suggested Entry: $60.50 (above the 30-day MA) - Stop Loss: $58.50 (below the 60D low) - Take Profit Targets: 1. $62.00 (approx. 2.5% gain) 2. $63.50 (approx. 5.8% gain) 3. $70.00 (approx. 16.5% gain) Target 3 offers a potential ROI of over 17%. Monitor price action closely for signs of strength or weakness. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TimRegan_WTR
TimRegan_WTR Nov. 18 at 6:32 PM
0 · Reply
research_WTR
research_WTR Nov. 18 at 6:22 PM
Prestige Consumer Healthcare (PBH) Posts Solid 2QFY26 — EPS Beat, Strong FCF, and Accelerated Buybacks 🔹 Sales of $274M, down 3.4% Y/Y but ahead of PBH guidance & consensus, helped by earlier-than-expected Clear Eyes inventory and strong online orders 🔹 Clear Eyes supply constraints easing — two new suppliers online; high-speed line coming via Pillar5 acquisition 🔹 Adjusted EBITDA of $86.8M, above expectations, with solid margins 🔹PBH continues to deliver resilient performance, strong cash generation, and disciplined capital allocation — positioning the company well heading into FY26/FY27. Read Douglas M. Lane, CFA full report for more! $PBH #Earnings #ConsumerHealth #ClearEyes #SmallCap #Stocks #Investing #FreeCashFlow #Buybacks
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:57 PM
Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 100 → 88.
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 7 at 2:14 PM
$PBH Current Stock Price: $61.40 Contracts to trade: $60 PBH Nov 21 2025 Call Entry: $3.54 Exit: $6.53 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Nov. 6 at 11:00 AM
$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act
0 · Reply
Estimize
Estimize Nov. 4 at 11:03 PM
Wall St is expecting 0.97 EPS for $PBH Q2 [Reporting 11/06 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 1:36 PM
Oppenheimer has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Outperform with a target price of 82 → 72.
0 · Reply
TheDailyDirtnap
TheDailyDirtnap Oct. 5 at 4:30 PM
$PBH Consumer products consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength.
0 · Reply
Sidoti
Sidoti Sep. 18 at 8:13 PM
Prestige Consumer Healthcare Inc. ($PBH) Management Team presented today at the Sidoti Small-Cap Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_eeOvc7BATUuTCaJFlyxGfg
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 6:36 AM
$PBH Really good write-up that perfectly summarizes PBH's present situation. So if you want to bring your PBH knowledge up to date or just discover PBH, this is required reading. https://beyondspx.com/quote/PBH/analysis/prestige-consumer-healthcare-fortifying-its-niche-amidst-supply-headwinds-and-strategic-acquisitions-nyse-pbh
0 · Reply
Mohamed209
Mohamed209 Aug. 13 at 9:37 PM
$PBH what’s going on here ?
0 · Reply
Mohamed209
Mohamed209 Aug. 13 at 9:36 PM
$PBH 👀
0 · Reply
TimRegan_WTR
TimRegan_WTR Aug. 13 at 4:57 PM
0 · Reply
research_WTR
research_WTR Aug. 13 at 4:48 PM
PBH 1QFY26 Misses Expectations Amid Clear Eyes Supply Challenges 🔹 Adjusted EPS $0.95 vs. $0.90 Y/Y, below expectations 🔹 Sales down 6.6% to $249.5M, driven by Clear Eyes plant shutdown & e-commerce inventory destocking 🔹 Adjusted EBITDA flat at $79.6M, margins up 210 bps 🔹 Two new Clear Eyes suppliers onboarded; acquiring Pillar5 to gain control over production Prestige Consumer Healthcare expects Clear Eyes shipments to improve in the December quarter as supply constraints ease. Continue to follow along with Doug Lane! https://www.watertowerresearch.com/doc?docID=UR_PBH_08122025 $PBH #Consumer #Health #EarningsUpdate #SupplyChain #HealthcareInvesting #SmallCap #Stocks #Investing #InvestorInsights
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 10:00 PM
Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 105 → 100.
0 · Reply
Lavaman76
Lavaman76 Jul. 16 at 1:20 PM
$PBH Got into PBH - way oversold and looking for run-up into earnings. https://schrts.co/ruacehbJ
0 · Reply
Estimize
Estimize Jul. 2 at 8:00 PM
Wall St is expecting 1.00 EPS for $PBH Q1 [Reporting 07/31 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont
0 · Reply
Estimize
Estimize Jun. 19 at 12:03 PM
Wall St is expecting 1.00 EPS for $PBH Q1 [Reporting 07/31 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 1:24 PM
$PBH rallies 30.9% in a year — what’s driving the momentum? 🚀 💡 Strong e-commerce growth in fiscal 2025 and strategic acquisitions are fueling PBH’s expansion, with digital strategies boosting consumer engagement. Despite currency and unfavorable solvency headwinds, the company’s diverse brand portfolio remains robust. Discover the full growth strategy here 👉 https://www.zacks.com/commentary/2494085/should-you-continue-to-hold-prestige-consumer-stock-in-your-portfolio?cid=sm-stocktwits-2-2494085-body&ADID=SYND_STOCKTWITS_TWEET_2_2494085_BODY
0 · Reply